相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Extended Survival After Surgical Resection for Pituitary Metastases: Clinical Features, Management, and Outcomes of Metastatic Disease to the Sella
Krupa R. Patel et al.
ONCOLOGIST (2020)
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma
Omid Hamid et al.
CANCERS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Early and late relapses of cutaneous melanoma patients
Faruk Tas et al.
POSTGRADUATE MEDICINE (2019)
Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review
Austin Greco et al.
CANCERS (2019)
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The mRNA expression of PTTG1 is a strong prognostic indicator for recurrence after hypophysectomy in dogs with corticotroph pituitary adenomas
N. Vastenhout et al.
VETERINARY JOURNAL (2018)
Pituitary metastasis: a rare condition
Aida Javanbakht et al.
ENDOCRINE CONNECTIONS (2018)
Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis A case report and literature review
Chuanwei Yang et al.
MEDICINE (2017)
Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib
Simona Caporali et al.
ONCOTARGET (2017)
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
R. Dummer et al.
ANNALS OF ONCOLOGY (2015)
Pituitary metastases: current practice in Japan
Mika Habu et al.
JOURNAL OF NEUROSURGERY (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis
Wenzhuan He et al.
PITUITARY (2015)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Caroline Robert et al.
LANCET (2014)
Pituitary Apoplexy Caused by Hemorrhage From Pituitary Metastatic Melanoma: Case Report
Katsuya Masui et al.
NEUROLOGIA MEDICO-CHIRURGICA (2013)
BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
Maria Colombino et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
Melanoma of the sellar region
Y. Y. Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
Intracranial metastatic disease rarely involves the pituitary: retrospective analysis of 935 metastases in 155 patients and review of the literature
James C. Marsh et al.
PITUITARY (2010)
Epidemiology of invasive cutaneous melanoma
R. M. MacKie et al.
ANNALS OF ONCOLOGY (2009)
Melanoma epidemiology and trends
Claus Garbe et al.
CLINICS IN DERMATOLOGY (2009)
Multiple intracranial melanoma metastases: case report and review of the literature
Aslan Guzel et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Metastatic melanoma to the pituitary gland
Ian E. McCutcheon et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2007)
Pituitary tumor-transforming gene: Physiology and implications for tumorigenesis
George Vlotides et al.
ENDOCRINE REVIEWS (2007)
A man in his mid-70s with a sellar mass - Diagnosis - Pituitary oncocytoma with metastatic malignant melanoma.
Shih-Ming Jung et al.
BRAIN PATHOLOGY (2007)
Tumors metastatic to the pituitary gland: Case report and literature review
J Komninos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Metastatic melanoma of the pituitary gland - Case report
GKK Leung et al.
JOURNAL OF NEUROSURGERY (2003)
分享论文
